Association Between Plasma Trimethyllysine and Prognosis of Patients With Ischemic Stroke,Journal of the American Heart Association

当前位置： X-MOL 学术 › J. Am. Heart Assoc. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Association Between Plasma Trimethyllysine and Prognosis of Patients With Ischemic Stroke
Journal of the American Heart Association ( IF 5.4 ) Pub Date : 2021-11-24 , DOI: 10.1161/jaha.121.020979
Jie Xu ₁ , Mingming Zhao ₂ , Anxin Wang ₁ , Jing Xue ₁ , Si Cheng ₁ , Aichun Cheng ₁ , Jianing Gao ₂ , Qi Zhang ₂ , Rui Zhan ₂ , Xia Meng ₁ , Ming Xu ₃ , Hao Li ₁ , Lemin Zheng _{1,

2} , Yongjun Wang ₁

Affiliation

BackgroundTrimethyllysine, a trimethylamine N‐oxide precursor, has been identified as an independent cardiovascular risk factor in acute coronary syndrome. However, limited data are available to examine the role of trimethyllysine in the population with stroke. We aimed to examine the relationship between plasma trimethyllysine levels and stroke outcomes in patients presenting with ischemic stroke or transient ischemic attack.Methods and ResultsData of 10 027 patients with ischemic stroke/transient ischemic attack from the CNSR‐III (Third China National Stroke Registry) and 1‐year follow‐up data for stroke outcomes were analyzed. Plasma levels of trimethyllysine were measured with mass spectrometry. The association between trimethyllysine and stroke outcomes was analyzed using Cox regression models. Mediation analysis was performed to examine the mediation effects of risk factors on the associations of trimethyllysine and stroke outcomes. Elevated trimethyllysine levels were associated with increased risk of cardiovascular death (quartile 4 versus quartile 1: adjusted hazard ratio [HR], 1.72; 95% CI, 1.03–2.86) and all‐cause mortality (quartile 4 versus quartile 1: HR, 1.97; 95% CI, 1.40–2.78) in multivariate Cox regression model. However, no associations were found between trimethyllysine and nonfatal stroke recurrence or nonfatal myocardial infarction. Trimethyllysine was associated with cardiovascular death independent of trimethylamine N‐oxide. Both estimated glomerular filtration rate and hs‐CRP (high‐sensitivity C‐reactive protein) had significant mediation effects on the association of trimethyllysine with cardiovascular death, with a mediation effect of 37.8% and 13.4%, respectively.ConclusionsElevated trimethyllysine level is associated with cardiovascular death among patients with ischemic stroke/transient ischemic attack. Mediation analyses propose that trimethyllysine contributes to cardiovascular death through inflammation and renal function, suggesting a possible pathomechanistic link.

更新日期：2021-12-07

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>